Daewoong completes AI-based drug development system
South Korean pharmaceutical giant Daewoong Pharmaceutical said Monday that it has completed a new drug development system that secures drug candidates based on artificial intelligence technology. It created a collection of 800 million preprocessed molecular models, called Daewoong Advanced Virtual Database, or DAVID, and a separate AI system, called Daewoong AI System, or DAVIS, to nurture new drug candidates through...
Source: koreaherald.com